Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Fluoxetine for Multiple Sclerosis Publisher



Hosseini R1 ; Tajdini M2 ; Modabbernia A3 ; Akhondzadeh S4 ; Tafakhori A5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Massachusetts General Hospital, Radiology, Harvard University, 55 Fruit Street, Boston, 02114, MA, United States
  2. 2. Tehran University of Medical Sciences, Tehran Heart Centre, South Kargar Street, Tehran, 13337, Iran
  3. 3. Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Department of Psychiatry, South Kargar Street, Tehran, 13337, Iran
  4. 4. Tehran University of Medical Sciences, Department of Psychiatry, Roozbeh Psychiatric Hospital, South Kargar Street, Tehran, 13337, Iran
  5. 5. Tehran University of Medical Sciences, Department of Neurology, Keshavarz Blv, Tehran, Iran

Source: Cochrane Database of Systematic Reviews Published:2018


Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The objectives of this review is to assess the efficacy and safety of fluoxetine to modify the course of the disease in people with multiple sclerosis. © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Related Docs
View other Related Docs
1. Consensus Recommendations for the Diagnosis and Treatment of Multiple Sclerosis: 2019 Revisions to the Menactrims Guidelines, Multiple Sclerosis and Related Disorders (2020)
2. Smoking and Worsening Disability in Multiple Sclerosis: A Meta-Analysis, Acta Neurologica Scandinavica (2018)
3. Consensus Recommendations for the Diagnosis and Treatment of Multiple Sclerosis: The Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis (Menactrims), Current Medical Research and Opinion (2015)
4. Multiple Sclerosis Epidemiology in East Asia, South East Asia and South Asia: A Systematic Review, Neuroepidemiology (2016)
5. An Interleukin 12 B Single Nucleotide Polymorphism Increases Il-12P40 Production and Is Associated With Increased Disease Susceptibility in Patients With Relapsing-Remitting Multiple Sclerosis, Neurological Research (2017)
6. Multiple Sclerosis: Clinical Features, Pathophysiology, Diagnosis, and Management, Neuroinflammation (2018)
7. Dysregulation of Micrornas Regulating Survivin in Cd4+ T Cells in Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2020)
8. Multiple Sclerosis Epidemiology in Middle East and North Africa: A Systematic Review and Meta-Analysis, Neuroepidemiology (2015)
Experts (# of related papers)
View all Related Experts
Mohammad Ali Sahraian (29)
Amirreza Azimi (7)
Other Related Docs
9. Genetic Polymorphisms and Epigenetic Regulation of Survivin Encoding Gene, Birc5, in Multiple Sclerosis Patients, BMC Immunology (2019)
10. Clinical Characteristics and Disability Progression of Early-And Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis, Journal of Clinical Medicine (2020)
11. Channelopathy-Related Scn10a Gene Variants Predict Cerebellar Dysfunction in Multiple Sclerosis, Neurology (2016)
12. Covid-19 and Its Implications on the Clinico-Radiological Course of Multiple Sclerosis: A Case–Control Study; [Covid-19 Y Sus Implicaciones En El Curso Clinico-Radiologico De La Esclerosis Multiple: Un Estudio De Casos Y Controles], Medicina Clinica (2023)
13. Consensus Recommendations for Diagnosis and Treatment of Multiple Sclerosis: 2023 Revision of the Menactrims Guidelines, Multiple Sclerosis and Related Disorders (2024)
14. The Epidemiologic Trend of Multiple Sclerosis in Razavi Khorasan Province, Iran in Fifteen-Year Period, Multiple Sclerosis and Related Disorders (2025)
15. Osteopontin (Opn) As a Csf and Blood Biomarker for Multiple Sclerosis: A Systematic Review and Meta-Analysis, PLoS ONE (2018)
16. Serostatus of Epstein–Barr Virus in Iranian Ms Patients, Acta Neurologica Belgica (2016)
17. Plasma Levels of Ctrp-3, Ctrp-9 and Apelin in Women With Multiple Sclerosis, Journal of Neuroimmunology (2019)
18. Downregulation of Immunosuppressive Molecules, Pd-1 and Pd-L1 But Not Pd-L2, in the Patients With Multiple Sclerosis, Iranian Journal of Allergy# Asthma and Immunology (2016)
19. Primary Progressive Multiple Sclerosis in Iran: A Consensus Recommendation for Diagnosis and Management, Multiple Sclerosis and Related Disorders (2018)
20. The Role of Cerebellar Abnormalities in Neuromyelitis Optica - a Comparison With Multiple Sclerosis and Healthy Controls, Multiple Sclerosis (2015)
21. Up Regulation of Mmp9 Gene Expression in Female Patients With Multiple Sclerosis, Human Antibodies (2016)
22. Plp1 Mutations in Patients With Multiple Sclerosis: Identification of a New Mutation and Potential Pathogenicity of the Mutations, Journal of Clinical Medicine (2018)
23. Prevalence and Predictors of Dysphagia in Iranian Patients With Multiple Sclerosis, Medical Journal of the Islamic Republic of Iran (2017)
24. Biomechanical Changes of the Common Carotid Artery and Internal Jugular Vein in Patients With Multiple Sclerosis, Ultrasonography (2023)
25. The Effects of Omega-3 Supplementation on the Expanded Disability Status Scale and Inflammatory Cytokines in Multiple Sclerosis Patients: A Systematic Review and Meta-Analysis, CNS and Neurological Disorders - Drug Targets (2019)
26. Low Dose Aspirin for Ms-Related Fatigue: Results of a Pilot, Double-Blind, Randomized Trial, Neurology Psychiatry and Brain Research (2017)
27. The Role of the Cerebellum in Multiple Sclerosis, Cerebellum (2015)
28. Early-Onset Multiple Sclerosis: Reports of 300 Patients From Iran, Journal of Pediatric Neurosciences (2018)
29. Utility of Myelin Basic Protein As an Early Prognostic Biomarker in Multiple Sclerosis, Iranian Red Crescent Medical Journal (2017)
30. Association Study of Two Functional Single Nucleotide Polymorphisms of Neuropeptide Y Gene With Multiple Sclerosis, Neuropeptides (2016)
31. B Cells in Multiple Sclerosis Therapy—A Comprehensive Review, Acta Neurologica Scandinavica (2018)
32. Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran, Iranian Journal of Public Health (2017)
33. Physical Activity May Contribute to Brain Health in Multiple Sclerosis: An Mr Volumetric and Spectroscopy Study, Journal of Neuroimaging (2021)
34. Personality Characteristics in Ms Patients: The Role of Avoidant Personality, Clinical Neurology and Neurosurgery (2016)
35. Functional Clinical Outcomes in Multiple Sclerosis: Current Status and Future Prospects, Multiple Sclerosis and Related Disorders (2015)
36. Effects of Eight-Week Resistance Training Program in Men With Multiple Sclerosis, Asian Journal of Sports Medicine (2015)
37. Deficiency in Mental Rotation of Upper and Lower-Limbs in Patients With Multiple Sclerosis and Its Relation With Cognitive Functions, Acta Medica Iranica (2016)
38. Environmental Risk Factors of Multiple Sclerosis in the Middle East and North Africa Region: A Systematic Review, Current Journal of Neurology (2021)
39. Combination Treatment of Docosahexaenoic Acid (Dha) and All-Trans-Retinoic Acid (Atra) Inhibit Il-17 and Rorγt Gene Expression in Pbmcs of Patients With Relapsing-Remitting Multiple Sclerosis, Neurological Research (2018)
40. Validity and Reliability of the Persian Version of the Perception De La Scle’Rose En Plaques Et De Ses Pousse’Es Questionnaire Evaluating Multiple Sclerosis-Related Quality of Life, International Journal of Preventive Medicine (2016)
41. Differential Serostatus of Epstein-Barr Virus in Iranian Ms Patients With Various Clinical Patterns, Medical Journal of the Islamic Republic of Iran (2018)
42. Disease-Modifying Therapies and T1 Hypointense Lesions in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis, CNS Neuroscience and Therapeutics (2022)
43. Increased Serum Brain-Derived Neurotrophic Factor in Multiple Sclerosis Patients on Interferon-B and Its Impact on Functional Abilities, Neurologist (2015)
44. Association of Two Polymorphisms in Msh2 and Xrcc1 Genes With Multiple Sclerosis in Iranian Population, Physiology and Pharmacology (2016)
45. The Association of Ebv and Hhv-6 Viral Load With Different Nk and Cd8+ T Cell Subsets in the Acute Phase of Relapsing-Remitting Multiple Sclerosis, Cell Journal (2021)
46. The Role of Candida Albicans in the Severity of Multiple Sclerosis, Mycoses (2016)
47. Two Functional Promoter Polymorphisms of Neuregulin 1 Gene Are Associated With Progressive Forms of Multiple Sclerosis, Journal of the Neurological Sciences (2015)
48. Stem Cell Therapy for Multiple Sclerosis, Cochrane Database of Systematic Reviews (2018)
49. Home-Based Exercise Training Influences Gut Bacterial Levels in Multiple Sclerosis, Complementary Therapies in Clinical Practice (2021)
50. Comparison of Cytokine Expression in Multiple Sclerosis Patients and Healthy Volunteers, Acta Medica Iranica (2018)